U.S. General Merchandise and Department Stores Stock News

NYSE:BRK.B
NYSE:BRK.BDiversified Financial

Berkshire Hathaway (BRK.B) And Warren Buffett's 2034 Giving Plan Just Changed Course

Warren Buffett plans to donate all remaining Berkshire Hathaway shares by 2034, accelerating his long standing giving program. Future donations will exclude the Gates Foundation, ending one of the most prominent philanthropic partnerships tied to Berkshire Hathaway stock. The shift redirects Berkshire shares toward other foundations and raises fresh questions about the future composition of the shareholder base. Berkshire Hathaway (NYSE:BRK.B) sits at the center of this philanthropy shift...
NYSE:UNFI
NYSE:UNFIConsumer Retailing

United Natural Foods (UNFI) Reshuffles Leadership, Is The Stock Fairly Valued?

United Natural Foods (UNFI) is reshaping its senior leadership, with current Chief Financial Officer Matteo Tarditi moving into the President and Chief Operating Officer role and experienced finance executive Alfredo Luchini appointed as the next CFO. See our latest analysis for United Natural Foods. The leadership reshuffle comes after a year in which United Natural Foods’ share price has moved around but still sits at US$48.52, with strong year to date share price performance and multi year...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

The Bull Case For Natera (NTRA) Could Change Following New Signatera JAMA Oncology Evidence On MRD-Guided Chemotherapy

Natera, Inc. recently reported that Monica Bertagnolli resigned from its Board of Directors on July 1, 2026, following her appointment to the National Academy of Medicine, with the company confirming her departure was unrelated to any disagreement over operations, policies, or practices. The company also announced new JAMA Oncology data from the GALAXY arm of CIRCULATE-Japan showing its Signatera MRD test can help identify which patients with resected colorectal liver metastases gain...
NYSE:KD
NYSE:KDIT

Kyndryl (KD) Teams Up With Aptiv For Mission Critical Edge And Cloud Push

Kyndryl Holdings (NYSE:KD) has entered into an alliance with Aptiv focused on mission-critical innovation. The partnership combines Aptiv’s Wind River software with Kyndryl’s advisory, implementation, and managed services. The collaboration targets customers that require high reliability and performance across global markets. Kyndryl Holdings, trading under ticker NYSE:KD, is expanding its presence in mission-critical environments through an alliance with Aptiv. By working with Aptiv’s Wind...
NasdaqGS:FROG
NasdaqGS:FROGSoftware

JFrog (FROG) Lands Canada Procurement Win Following A Narrative That Still Looks Pricey

JFrog (FROG) is drawing attention after its software supply chain platform was added to the Government of Canada's Software Licensing Supply Arrangement Catalogue, giving federal agencies a standardized way to procure its tools. See our latest analysis for JFrog. That Canadian procurement win lands as JFrog’s recent 30-day share price return of 13.55% and 90-day share price return of 109.26% signal strong momentum, while the 1-year total shareholder return of 126.50% highlights how materially...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Crocs Stock And The Tariff Shift Investors Should Watch

U.S. tariffs on a wide range of Brazilian imports are reshaping where American companies source key products, and that shift could matter for your portfolio. As costs rise for imported machinery, apparel, footwear, electrical equipment, paper, and some chemicals, U.S. based suppliers may see new demand from buyers looking closer to home. This article looks at three stocks exposed to that trade story, all drawn from a U.S. Import Substitution Stocks screener built around the latest tariff...
NYSE:BWMX
NYSE:BWMXSpecialty Retail

Celestica Stock And 2 Growth Picks for Cooling Inflation

Cooling inflation and the possibility of slower rate hikes are reshaping where growth investors are looking for opportunity. With headline inflation at 3.5% in June and the Fed hinting that further increases may be reconsidered if this trend holds, earnings expectations and valuations across growth stocks can shift quickly. This article uses our Growth Stocks screener, built around that inflation and interest rate backdrop, to spotlight 3 stocks that appear well positioned to benefit from the...
NYSE:GWRE
NYSE:GWRESoftware

Guidewire (GWRE) Stock Looks Like A Bargain On Cash Flow But Rich On Earnings

Guidewire Software's valuation is pulling in two directions right now, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting the stock trades at a 32.4% discount, while market multiples make it look expensive on more traditional pricing metrics. Over the past 3 years, Guidewire Software has returned 76.0%, which puts the recent share price in the context of a longer period of solid investor gains. Recent earnings news has supported expectations for further revenue growth,...
NYSE:SSTK
NYSE:SSTKInteractive Media and Services

Why Shutterstock (SSTK) Is Down 11.5% After CEO Exit And Failed Getty Merger - And What's Next

On July 13, 2026, Shutterstock, Inc. announced that Chief Executive Officer and longtime board member Paul Hennessy stepped down, with Chief Financial Officer Rik Powell assuming the role of Interim CEO while retaining his CFO responsibilities during the transition. This leadership change comes just days after Getty Images canceled its planned merger with Shutterstock following UK regulators’ requirement that Shutterstock divest its editorial business, leaving the company to reset its...
NasdaqGS:VOR
NasdaqGS:VORBiotechs

Can Vor Biopharma’s (VOR) New Board Appointment Reshape Its Late-Stage Commercialization Strategy?

Vor Biopharma recently appointed David Zaccardelli, Pharm.D., to its Board of Directors, adding a leader who has guided multiple biopharmaceutical companies through late-stage development, regulatory approvals, commercial launches, and acquisitions, including Verona Pharma’s US$10 billion sale to Merck in 2025. His track record in advancing therapies from clinical programs to approved products and in raising over US$1 billion for development and commercialization efforts introduces...
NasdaqGS:TCBI
NasdaqGS:TCBIBanks

Texas Capital Bancshares (TCBI) Appoints Mo Jamous To Lead Its Digital Push

Texas Capital Bancshares (NasdaqGS:TCBI) has appointed Mo Jamous as Managing Director, Chief Digital and Information Officer. Jamous is set to lead the company's technological transformation, including digital banking, technology infrastructure, and AI driven solutions. He brings experience in digital banking and AI enablement from prior roles at U.S. Bank and BBVA. For Texas Capital Bancshares, a commercial and consumer banking company, this leadership change comes as digital channels and...
NasdaqGS:ALGM
NasdaqGS:ALGMSemiconductor

How Investors Are Reacting To Allegro MicroSystems (ALGM) ASIL-D Brake-by-Wire Power Management Launch

Allegro MicroSystems recently launched the A81415, described as the industry's first ASIL-D-certified power management IC that integrates a wheel-speed sensor interface, aiming to simplify electromechanical braking and next-generation brake-by-wire designs. By combining power regulation, wheel-speed signal decoding, and support for Allegro’s XtremeSense TMR sensors in one chip, the A81415 seeks to cut component count, free up more than half of the brake-caliper board space, and trim latency...
NasdaqGM:LGND
NasdaqGM:LGNDPharmaceuticals

Ligand Pharmaceuticals (LGND) Closes XOMA Deal, Is The Stock Still Below Fair Value?

Ligand Pharmaceuticals (LGND) has completed its approximately US$739 million cash acquisition of XOMA Royalty Corporation, adding seven commercial products and more than 100 development and commercial stage assets to its royalty portfolio of more than 200 assets. See our latest analysis for Ligand Pharmaceuticals. Ligand Pharmaceuticals’ latest move comes after a strong run in the stock, with the share price up 55.84% year to date and supported by a 128.54% 1 year total shareholder return...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet (PODD) Stock May Be Above Fair Value On Recall Lawsuit Risk

Insulet stock has fallen sharply over the past year, yet on current market multiples it still screens as expensive. This leaves investors weighing a weak share price record against valuation checks that do not flag a clear bargain. Insulet has declined 44.7% over the last 12 months, which means the stock has given back a large amount of value despite more recent short term gains. Product quality issues and related recalls around the Omnipod franchise can weigh on sentiment, while ongoing...
NasdaqGS:OPRA
NasdaqGS:OPRASoftware

Did DMA-Fueled Mobile User Surge Just Shift Opera's (OPRA) Investment Narrative?

Opera reported that in the second quarter its combined monthly active users on Android and iOS browsers grew 66% in the UK and 40% in the US year over year, helped by the EU's 2024 Digital Markets Act opening up browser choice on iOS. This surge highlights how regulatory change, paired with Opera’s built-in AI, unlimited VPN and improved cross-device sync, can meaningfully shift user behavior in mature mobile markets. Against this backdrop, we’ll examine how Opera’s rapid mobile user growth,...
NYSE:MKL
NYSE:MKLInsurance

Markel (MKL) Appoints Marc Copland To Lead Property Growth In Canada

Markel Insurance, part of Markel Group (NYSE:MKL), appointed Marc Copland as Vice President, Product Line Leader, Property in Canada. Copland will focus on expanding Markel Canada's Property portfolio and using technology to support product development. The role is intended to reinforce Markel Canada's position in the specialty insurance market. For shareholders watching how Markel Group positions its insurance operations, this appointment highlights attention on the Canadian Property...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Illumina (ILMN) Expands Billion Cell Atlas Alliance With New AI Drug Discovery Members

Illumina expanded its Billion Cell Atlas alliance with three new members, including AI-first drug developer Formation Bio. The alliance aims to build and share what is described as the world's largest genomic perturbation data set. The expansion is intended to speed up AI-driven drug discovery and target validation through large-scale genomic collaboration. For investors watching Illumina (NasdaqGS: ILMN), this alliance update adds a fresh angle to a stock that has recently shown strong...
NYSE:RKT
NYSE:RKTDiversified Financial

Rocket Companies (RKT) Stock Looks Cheap On Sales Yet Fair On Value

Rocket Companies stock has delivered a 43.4% return over the past 3 years, yet the current checks present a mixed valuation picture where the Excess Returns intrinsic value estimate points to a roughly fair price while the market multiples suggest the shares may still be on the cheap side. Over 3 years, Rocket Companies has returned 43.4%, which puts recent share performance firmly in positive territory for longer term holders. The scale of Rocket’s $2.1b servicing portfolio, along with...
NasdaqGS:XMTR
NasdaqGS:XMTRTrade Distributors

Xometry Stock And The US Industrial Shift Investors Are Watching

Tariff policy is back in the spotlight after the Supreme Court ruling on emergency tariff powers and the approaching expiry of current Section 122 tariffs. For domestic manufacturing and industrial stocks, this mix of lost tariff revenue, possible Section 301 actions, and extended uncertainty around global trade could reshape where capital and risk sit. This article looks at three U.S. based companies from a Domestic Manufacturing and Industrial Stocks screener that are closely exposed to...
NasdaqGS:WERN
NasdaqGS:WERNTransportation

Do Upgraded Earnings Estimates Recast Werner’s (WERN) Logistics Expansion Strategy or Just Analyst Sentiment?

Recently, Werner Enterprises received a Zacks Rank #2 rating after analysts raised their earnings estimates, reflecting growing optimism about the company’s earnings outlook. This shift in expectations comes despite earlier concerns about weaker sales and profitability, highlighting how analyst sentiment can change the perceived risk profile of the business. Now, we will explore how these upgraded earnings expectations reshape Werner’s existing investment narrative built around capacity...
NYSE:FIGS
NYSE:FIGSLuxury

Should Zacks’ Upgrade and Earnings Optimism Require Action From FIGS (FIGS) Investors?

Earlier this week, Zacks upgraded Figs (FIGS) to a Rank #2 rating, citing an upward trend in analyst earnings estimate revisions and growing optimism around the company’s earnings outlook. This shift in analyst sentiment highlights how changes in earnings expectations alone can materially influence perceptions of FIGS’ underlying business momentum. With this earnings-estimate upgrade in mind, we’ll now examine how the changed outlook could interact with FIGS’ existing margin-recovery...
NYSE:CSTM
NYSE:CSTMMetals and Mining

Constellium (CSTM) Signs 10 Year Solar Power Deal For German Plants

Constellium (NYSE:CSTM) has entered into a 10-year Power Purchase Agreement for solar electricity for its Gottmadingen and Singen plants in Germany. The agreement is expected to cover more than a quarter of the sites’ electricity needs and support annual CO₂ emissions reductions. The deal is part of Constellium’s broader sustainability approach and aims to support energy resilience and competitiveness in Germany. Constellium, a supplier of aluminum products and solutions, is tying a...
NYSE:VTR
NYSE:VTRHealth Care REITs

Ventas (VTR) Lifts Annualized Dividend 8.3% As Earnings Growth Supports Payout

Ventas (NYSE:VTR) has raised its annualized dividend rate, an 8.3% increase from last year. The new payout level reflects recent board action and updates the income profile for current and prospective shareholders. The change arrives as the company reports projected earnings improvements that support higher dividend distributions. Ventas operates as a real estate investment trust focused on healthcare properties, an area closely watched by income oriented investors. In this corner of the...
NYSE:SNX
NYSE:SNXElectronic

TD SYNNEX (SNX) Lands Fortinet Global Distributor Role For Bigger Cybersecurity Reach

TD SYNNEX has been named an approved global distributor for Fortinet, expanding its role in cybersecurity distribution worldwide. The agreement gives TD SYNNEX broader reach with global systems integrators and large international partners. The new status is expected to support multi region Fortinet deployments and centralized support for enterprise customers. TD SYNNEX (NYSE:SNX), currently trading at $250.08, has seen a strong run in its stock, with the share price up 63.0% year to date...